Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antiepileptogenic agents: how close are we?

N R Temkin1, A D Jarell, G D Anderson

  • 1Department of Neurological Surgery, University of Washington, Seattle 98104-2499, USA. temkin@biostat.washington.edu

Drugs
|July 24, 2001
PubMed
Summary

Preventing epilepsy development (epileptogenesis) is a potential strategy, but current antiepileptic drugs have shown disappointing results in clinical trials for preventing seizures. Primary prevention of risk factors remains the most effective approach.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The effect of nicotinamide on gene expression in a traumatic brain injury model.

Frontiers in neuroscience·2013
Same author

Can changes in angiogenic biomarkers between the first and second trimesters of pregnancy predict development of pre-eclampsia in a low-risk nulliparous patient population?

BJOG : an international journal of obstetrics and gynaecology·2013
Same author

Combination therapies that inhibit cyclooxygenase-2 and leukotriene synthesis prevent disease in murine collagen induced arthritis.

Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2009
Same author

Nicotinamide treatment induces behavioral recovery when administered up to 4 hours following cortical contusion injury in the rat.

Neuroscience·2008
Same author

The effect of telephone counselling on reducing post-traumatic symptoms after mild traumatic brain injury: a randomised trial.

Journal of neurology, neurosurgery, and psychiatry·2008
Same author

Rufinamide: Pharmacology, clinical trials, and role in clinical practice.

International journal of clinical practice·2006

Area of Science:

  • Neurology
  • Neuroscience
  • Pharmacology

Background:

  • Epilepsy affects approximately 4% of individuals lifetime.
  • Epilepsy can be idiopathic, genetic, or acquired, with known causes accounting for one-third of cases.
  • Current epilepsy management focuses on suppressing seizures after onset, rather than preventing the underlying process of epileptogenesis.

Purpose of the Study:

  • To explore the potential of preventing epileptogenesis, the process of epilepsy development.
  • To review laboratory models and drug candidates for antiepileptogenic effects.
  • To evaluate the efficacy of existing and novel antiepileptic drugs in preventing epilepsy in humans.

Main Methods:

  • Utilized laboratory models like kindling and chemical injections to study epileptogenesis.

Related Experiment Videos

  • Reviewed studies on antiepileptic drugs (e.g., phenobarbital, valproate, levetiracetam) for antiepileptogenic potential.
  • Analyzed clinical trial data and meta-analyses of drugs tested for preventing unprovoked seizures.

    • Main Results:

    • Laboratory models and some drugs show promise for antiepileptogenic effects.
    • Clinical trials of established antiepileptic drugs (phenobarbital, phenytoin, valproate, carbamazepine, diazepam) to prevent epileptogenesis yielded disappointing results.
    • Meta-analyses indicated no significant reduction in unprovoked seizures; some drugs even showed a slight increase in seizure rates.

    Conclusions:

    • Current antiepileptic drugs have failed to demonstrate significant antiepileptogenic effects in human clinical trials.
    • Novel drugs have not yet been evaluated for their ability to prevent epileptogenesis.
    • Primary prevention of risk factors (e.g., head injury, stroke) is currently the most effective strategy to reduce epilepsy incidence.